Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-10-20
DOI
10.1038/srep35788
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation
- (2016) José Alexandre Ferreira et al. DRUG RESISTANCE UPDATES
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
- (2016) Caroline Wigerup et al. PHARMACOLOGY & THERAPEUTICS
- Prognostic Factors of Primary Intraosseous Squamous Cell Carcinoma (PIOSCC): A Retrospective Review
- (2016) Xu Wenguang et al. PLoS One
- Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment
- (2016) Shengwei Han et al. Oncotarget
- Repurposing metformin for cancer treatment: current clinical studies
- (2016) Young Kwang Chae et al. Oncotarget
- Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions
- (2016) Hongliang Yu et al. Biomed Research International
- The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil
- (2015) Marzia B. Gariboldi et al. CANCER LETTERS
- Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes
- (2015) Hengyi Chen et al. CANCER LETTERS
- Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization
- (2015) Carina Fischer et al. Molecular Cancer
- Metformin: A Novel but Controversial Drug in Cancer Prevention and Treatment
- (2015) Xinbing Sui et al. MOLECULAR PHARMACEUTICS
- Inflammation and cancer: Till death tears them apart
- (2015) T.P. Raposo et al. VETERINARY JOURNAL
- Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones)
- (2014) Leonard Howard Damelin et al. BMC CANCER
- Metformin Sensitizes EGFR-TKI-Resistant Human Lung Cancer Cells In Vitro and In Vivo through Inhibition of IL-6 Signaling and EMT Reversal
- (2014) L. Li et al. CLINICAL CANCER RESEARCH
- Use of Metformin Alone Is Not Associated with Survival Outcomes of Colorectal Cancer Cell but AMPK Activator AICAR Sensitizes Anticancer Effect of 5-Fluorouracil through AMPK Activation
- (2014) Xinbing Sui et al. PLoS One
- Oral squamous cell carcinoma in relation to field precancerisation: pathobiology
- (2013) Liviu L Feller et al. Cancer Cell International
- Overexpression of HIF-1α indicates a poor prognosis in tongue carcinoma and may be associated with tumour metastasis
- (2013) YANG ZHENG et al. Oncology Letters
- Metformin use and improved response to therapy in rectal cancer
- (2013) Heath D. Skinner et al. Cancer Medicine
- Metformin use and improved response to therapy in esophageal adenocarcinoma
- (2012) Heath D. Skinner et al. ACTA ONCOLOGICA
- Expression of glucose transporters in cancers
- (2012) Leszek Szablewski BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway
- (2012) Rabbie K. Hanna et al. GYNECOLOGIC ONCOLOGY
- Global estimates of cancer prevalence for 27 sites in the adult population in 2008
- (2012) Freddie Bray et al. INTERNATIONAL JOURNAL OF CANCER
- Metformin in cancer: translational challenges
- (2012) Ryan J O Dowling et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- Noscapine sensitizes chemoresistant ovarian cancer cells to cisplatin through inhibition of HIF-1α
- (2011) Wenjing Su et al. CANCER LETTERS
- Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
- (2011) D. Iliopoulos et al. CANCER RESEARCH
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- Epidemiology of cancer from the oral cavity and oropharynx
- (2011) René Lambert et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma
- (2011) Ke-Jun Nan INTERNATIONAL JOURNAL OF ONCOLOGY
- Metformin and cancer: new applications for an old drug
- (2011) Taxiarchis V. Kourelis et al. MEDICAL ONCOLOGY
- Evolutionary Conserved Regulation of HIF-1β by NF-κB
- (2011) Patrick van Uden et al. PLoS Genetics
- Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation
- (2010) Hyung Gyun Kim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
- (2010) I. Ben Sahra et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines
- (2010) Zhi-wei Yu et al. ORAL ONCOLOGY
- Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis
- (2009) Lavinia Nardinocchi et al. Molecular Cancer
- Regulation of hypoxia-inducible factor-1α by NF-κB
- (2008) Patrick van Uden et al. BIOCHEMICAL JOURNAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started